Purpose The purpose of this study is to identify papers that have produced the most significant impact on research on strategic alliances in the biotechnology industry. The authors attempt to illustrate the thematic evolution of its intellectual structure through 616 papers published between...

Purpose: This study evaluates the success metrics of post-merger and acquisition (M&A) activities in the German biopharmaceutical industry, focusing on small- and medium-sized enterprises (SMEs). It examines how metrics such as economies of scale, economies of scope, market share, clinical...

Today, the EU is at the heart of scientific research and innovation in new, bio-based manufacturing solutions that will bolster the industrial competitiveness and sustainability of our economies. Biotechnology has the potential to improve our quality of life through a range of breakthrough...

This report presents a patent landscape analysis investigating the innovation trends within the industrial biotechnology (IB) sector from 2015 to 2020. The study's primary objective is to identify the geographical hotspots of innovation, the key players, and the role of different types of...

Based on the analysis, this report finds that China has boosted its competitiveness in terms of technology generation across several green and digital technology fields. In particular, in 2021, China outperformed both the EU and the US in terms of patent applications in energy saving...

DNA carries the genetic instructions that dictate how organisms develop and function - acting as a blueprint for life. By digging deeper into genetic differences and harnessing the power of gene editing, EU-funded researchers are opening up new possibilities in the medical and biotech fields....

In terms of technology development, Japan is particularly strong in advanced materials and nanotechnology and in micro- and nanoelectronics and photonics, holding shares of transnational patent applications of at least 30% in these fields and therefore outperforming the EU in these domains. The...

The United States remains a strong innovator, but its technological competitiveness in certain green and digital technology fields particularly energy-saving technologies and quantum computing has declined over time. The US has maintained its global leadership when it comes to the development of...

Biotechnology firms operate in a highly innovative and capital-intensive environment, characterized by high levels of R&D, long product development periods, significant regulations, and high levels of uncertainty. These firms rely heavily on intangible assets, such as intellectual capital and...

This briefing identifies bio-based innovations with high potential to support the forthcoming updated EU bioeconomy strategy. The briefing also relates to broader EU climate and biodiversity goals, helping inform national and regional strategies. The analysis draws on data from EU and...

This Communication aims to unlock the full benefits of biotechnologies and biomanufacturing, which are crucial for the competitiveness and modernisation of EU industry and offer high growth and productivity potential.

The study explores entrepreneurial ecosystems, which emphasize the impact of regional context on entrepreneurship, with a particular focus on the health sector. Given its innovation and knowledge intensity, coupled with industry-specific challenges, the health sector serves as an ideal case for...

The biopharmaceutical sector is of considerable interest during the COVID-19 pandemic. This study aims to investigate the biopharmaceutical sector using the Shenwan Industry Classification and provides insights into investment strategies. We combine factor and cluster analyses to reduce data...

The link between entrepreneur's network centrality and innovation performance has been broadly studied in knowledge-intensive industries such as biotechnology. However, little research has been focused on the social mechanisms that allow innovators to reach such a central position. We contribute...

Corporate financial managers of biotech firms need long‐term financing to reach key milestones, and that requires a long‐ term capital structure. They must balance a mix of investors with different objectives and different investment horizons that includes traditional venture capitalists and...

Climate change has induced an ecological crisis necessitating reconsideration of how the law should manage human interactions with ecological systems. In most Western legal regimes, conservation policy has principally sought to advance historical or natural preservation or sustained yield...

Through a longitudinal study of the product development portfolios of 457 US-based firms in the biotechnology industry, we investigate how prolific inventors shape a firm’s innovative direction following product development failure. Contrary to received wisdom, we argue and demonstrate that an...

The continued impact of COVID-19 in the biotechnology sector is distinct from other industries, putting an additional strain on biotech employees. Like frontline workers, employees in biotechnology encounter circumstances where their performance is measured by life and death outcomes. Research...

The oil industry is responsible for production of many products in common use, such as plastic and fuel, which are used in various activities in modern society. However, the exploitation of these hydrocarbons has been considered aggressive to the environment and their reservoirs are not...

Apart from the basic statutory definition in section 65 of the Intellectual Property Act of Sri Lanka, there do not appear to be any detailed statutory guidelines or judicial decisions to provide any framework for the assessment of inventive step in Sri Lanka. The current statutory definition is...

Objective: The article aims to verify the development of innovation cooperation in the biopharmaceutical (biotech, pharma) industry in Central and Eastern Europe (CEE) taking into account the directions of innovation cooperation. I will try to verify the importance of location in innovation...

Research on how managers control R&D activities has tended to focus on the performance measurement systems used to exploit existing knowledge and capabilities. This focus has been at the expense of how broader forms of management control could be used to enable R&D contextual ambidexterity, the...

"Providing a comprehensive account of the latest research and thinking on the bioeconomy, Davide Viaggi brings together expert authors to reflect on the economics of using renewable biological resources to produce bio-based materials, food, energy and more, through a wide set of technological...

Biological drugs account for just two percent of prescriptions filled in the U.S. but fifty percent of prescription-drug spending. To explore the role patents play in explaining high biologics prices, we build the first comprehensive database of patents associated with all FDA-approved...

Biotechnology is a field which is utterly dependent on knowledge creation and management of novel innovations which are an outcome of contemporary knowledge. Knowledge management is a prime factor which determines the success or failure of a biotechnology company competing in the global...

Confronted with new global competitive environment, rising R&D costs, growing integration of different technologies, shorter life cycles, and increased pace of innovation, high-tech companies increasingly collaborate with external partners. Innovation networks became unconditional driver of...